Trials / Completed
CompletedNCT04042207
Diabeloop for Highly Unstable Type 1 Diabetes
In Adults With Very Unstable Type 1 Diabetes, is the DBLHU Closed-Loop Insulin Delivery System Able to Improve Blood Glycemic Control Compared to Low-Glucose-Predictive-Suspend System: Two-center, Randomized, Open-label Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète · Academic / Other
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
Feasibility study, comparing experimental treatment (DBLHU closed-loop system) with reference treatment (Low Glucose Predictive Suspend system) in 7 patients going through a series of N-of-1 trials. Each N-of-1 trial consists in a prospectively planned, multiple crossover study in a single individual. Two blocks of two periods of four weeks each (closed loop or open loop) will be conducted. Within each block, the sequence closed loop-open loop or open loop-close loop is randomized. Outcomes will be analyzed on the third and fourth weeks of period. A remote monitoring system managed by specialized nurse on behalf of diabetologist, is provided in closed-loop session. An extension period of 48 weeks with the DBLHU System (closed-loop condition) will be performed at the end of the crossover study phase in real life conditions (without remote monitoring).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Low Glucose Predictive Suspend system | consists of sensor-augmented pump therapy (SAP) / Low Glucose Predictive Suspend system (with predictive low glucose management technology) |
| DEVICE | DBLHU System | DBLHU system embeds a regulation algorithm to automatically regulate the patient's glycaemia. It takes as input glycaemia value received every 5 minutes from the CGM and patient inputs related to meals and physical activities and it calculates the amount of insulin to be delivered. It sends this information to the pump that automatically delivers this quantity. |
Timeline
- Start date
- 2019-09-03
- Primary completion
- 2020-02-27
- Completion
- 2021-03-22
- First posted
- 2019-08-01
- Last updated
- 2021-05-10
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04042207. Inclusion in this directory is not an endorsement.